The Impact of Assist Devices in the Prevention of Peritonitis

Nolph K. NIH National Registry Overview. Presented at the 8th National Conference on CAPD. Kansas City, Missouri, February 10, 1988.

Hamilton W. , Chareyton C. , Kurtz S. Reduction in peritonitis frequency by the DuPont Sterile Connection Device. Trans Am Soc Artif Intern Organs. 1985; 31: 651–654.

A multicenter study group. A randomized multicenter clinical trial to evaluate the effects of an ultraviolet germicidal system on peritonitis rate in continuous ambulatory peritoneal dialysis. Perit Dial Bull. 1985; 5: 19–24.

Verger C. , Luzar M.A. In-vitro study of the CAPD Y-line systems. In: Khanna R. ., eds. Advances in Continuous Peritoneal Dialysis. 1986: 160–164.

Rottembourgh J. , Brouard R. , Assad B. Prospective randomized study about Y connectors in CAPD patients. In: Khanna R. ., eds. Advances in Continuous Ambulatory Peritoneal Dialysis, 1987: 107–113.

Buonchristiani U. , Cozzari M. , Quintaliani G. Abatement of exogenous peritonitis risk using the Perugia CAPD system. Dial Trans. 1983; 12: 14–25.

Maiorca R. , Cantaluppi A. , Cancarini G.C. Prospective controlled trial of a Y connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet. 1983; 2: 642–644.

Lupo A. Italian multicenter study on CAPD: 8 years experience. Presented at the 8th National Conference on CAPD, Kansas City, Missouri, February 10–12, 1988.

Villano R. Multicenter evaluation of the “O” set in CAPD patients. Presented at the 8th National Conference on CAPD, Kansas City, Missouri, February 10–12, 1988.

Lempert K. , Kolb J. , Swartz R. A multicenter trial to evaluate the use of the CAPD “0” set. Trans Am Soc Artif Intern Organs. 1986; 32: 557–559.

Stason W. , Barnes B. The effectiveness and costs of continuous ambulatory peritoneal dialysis (CAPD). Contemporary Dialysis and Nephrology. 1985; 6: 28–32.